Pelthos Therapeutics Inc.
- Last sale
- Nov 12, 2026 · -16.25%
- Market cap
- $31.50M
- 3.93M shares
- Filings
- 261
Q3 2026
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+3,403.5% FY25 yoy
- $31.50M
- —
- 0.6×
- —
- -103.35%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $16,795,000 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $0.00 | $0.00 | — | 3.36M sh | −45.0% | — |
| FY2024 | — | $75.00K | $75.00K | — | 6.10M sh | +3.8% | — |
Segments
LineFY2025ShareChange
Commercial operations$16.21M96%—
Research and Development operations$589.00K3.5%—
Total$16.80M
Biological products, except diagnostic substances
Pelthos Therapeutics Inc. is the 56th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
MGXMetagenomi Therapeutics, Inc.$25.2M51.8%348.5%$27.0MALECAlector, Inc.$21.0M79.1%679.2%$363.3MLENZLENZ Therapeutics, Inc.$19.1M—430.3%$127.9M
PTHSPelthos Therapeutics Inc. (this company)$16.8M—257.9%$31.5M
RLAYRelay Therapeutics, Inc.$15.4M53.4%1,800.6%$4.0BLCTXLineage Cell Therapeutics, Inc.$14.6M53.2%436.5%$250.5MELUTElutia Inc.$12.3M15.0%434.2%$39.8MCRBUCaribou Biosciences, Inc.$11.2M11.7%1,327.4%$40.8MTCRXTScan Therapeutics, Inc.$10.3M266.7%1,256.8%$11.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Pelthos Therapeutics Inc. · CIK 1919246 · Engraved from SEC EDGAR